_id
6915f871bc934aba376b2591
Ticker
SHTPY
Name
SHTPY
Exchange
PINK
Address
Hattenbergstrasse 10, Mainz, Germany, 55122
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.schott-pharma.com
Description
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Last Close
4.37
Volume
-
Current Price
4.37
Change
0
Last Updated
2026-01-07T11:44:26.689Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
2632743680
Next Dividend Date
2026-02-23T00:00:00.000Z
Dividend Frequency
Annual
Dividend Rate
0.05261
Dividend Yield
4.815560640732265
Sentiment
0.9940000000000001
Sentiment Sources
3
Current Quarter
2025-07-31
Revenue
247583000
Cost Of Revenue
171501000
Gross Profit
76082000
Operating Expenses
206213000
Operating Income
41370000
Interest Expense
5461000
Pretax Income
41765000
Net Income
33555000
Eps
0.222787143048587
Dividends Per Share
0
Shares Outstanding
602458464
Income Tax Expense
-
EBITDA
-
Operating Margin
16.70954790918601
Total Other Income Expense Net
-
Cash
22470000
Short Term Investments
3196000
Receivables
201358000
Inventories
174975000
Total Current Assets
681401000
Property Plant Equipment
785673000
Total Assets
1598646000
Payables
103879000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
704897000
Equity
891783000
Bs_currency_symbol
EUR
Depreciation
22094000
Change In Working Capital
-1840000
Cash From Operations
52337000
Capital Expenditures
55458000
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-5945000
Cf_currency_symbol
EUR
PE
15.6071
PB
0.7380560875459613
ROE
3.762686662562529
ROA
2.0989637480718057
FCF
-3121000
Fcf Percent
-0.012605873585827782
Piotroski FScore
4
Health Score
51
Deep Value Investing Score
4.5
Defensive Investing Score
8
Dividend Investing Score
4
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
5.5
Value Investing Score
8.5
Quarters > 0 > quarter
2025-07-31
Quarters > 0 > income Statement > revenue
247583000
Quarters > 0 > income Statement > cost Of Revenue
171501000
Quarters > 0 > income Statement > gross Profit
76082000
Quarters > 0 > income Statement > operating Expenses
206213000
Quarters > 0 > income Statement > operating Income
41370000
Quarters > 0 > income Statement > interest Expense
5461000
Quarters > 0 > income Statement > pretax Income
41765000
Quarters > 0 > income Statement > net Income
33555000
Quarters > 0 > income Statement > eps
0.222787143048587
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
150614616
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
16.70954790918601
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
22470000
Quarters > 0 > balance Sheet > short Term Investments
3196000
Quarters > 0 > balance Sheet > receivables
201358000
Quarters > 0 > balance Sheet > inventories
174975000
Quarters > 0 > balance Sheet > total Current Assets
681401000
Quarters > 0 > balance Sheet > property Plant Equipment
785673000
Quarters > 0 > balance Sheet > total Assets
1598646000
Quarters > 0 > balance Sheet > payables
103879000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
704897000
Quarters > 0 > balance Sheet > equity
891783000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
33555000
Quarters > 0 > cash Flow > depreciation
22094000
Quarters > 0 > cash Flow > change In Working Capital
-1840000
Quarters > 0 > cash Flow > cash From Operations
52337000
Quarters > 0 > cash Flow > capital Expenditures
55458000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-5945000
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
0.222787143048587
Quarters > 0 > ratios > PB
0.7380560875459613
Quarters > 0 > ratios > ROE
3.762686662562529
Quarters > 0 > ratios > ROA
2.0989637480718057
Quarters > 0 > ratios > FCF
-3121000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
-0.012605873585827782
Quarters > 0 > health Score
51
Quarters > 1 > quarter
2025-04-30
Quarters > 1 > income Statement > revenue
256460000
Quarters > 1 > income Statement > cost Of Revenue
160361000
Quarters > 1 > income Statement > gross Profit
96099000
Quarters > 1 > income Statement > operating Expenses
196338000
Quarters > 1 > income Statement > operating Income
60122000
Quarters > 1 > income Statement > interest Expense
4914000
Quarters > 1 > income Statement > pretax Income
60139000
Quarters > 1 > income Statement > net Income
45564000
Quarters > 1 > income Statement > eps
0.3025204406456808
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
150614616
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
23.443032051781955
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
28288000
Quarters > 1 > balance Sheet > short Term Investments
12905000
Quarters > 1 > balance Sheet > receivables
168930000
Quarters > 1 > balance Sheet > inventories
167037000
Quarters > 1 > balance Sheet > total Current Assets
648453000
Quarters > 1 > balance Sheet > property Plant Equipment
747921000
Quarters > 1 > balance Sheet > total Assets
1528150000
Quarters > 1 > balance Sheet > payables
76837000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
663124000
Quarters > 1 > balance Sheet > equity
863257000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
45564000
Quarters > 1 > cash Flow > depreciation
19725000
Quarters > 1 > cash Flow > change In Working Capital
-7993000
Quarters > 1 > cash Flow > cash From Operations
55176000
Quarters > 1 > cash Flow > capital Expenditures
38289000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
2872000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
0.3025204406456808
Quarters > 1 > ratios > PB
0.7624448709017129
Quarters > 1 > ratios > ROE
5.278150075817514
Quarters > 1 > ratios > ROA
2.9816444720740765
Quarters > 1 > ratios > FCF
16887000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.06584652577399984
Quarters > 1 > health Score
58
Quarters > 2 > quarter
2025-01-31
Quarters > 2 > income Statement > revenue
252326000
Quarters > 2 > income Statement > cost Of Revenue
168610000
Quarters > 2 > income Statement > gross Profit
83716000
Quarters > 2 > income Statement > operating Expenses
202639000
Quarters > 2 > income Statement > operating Income
49687000
Quarters > 2 > income Statement > interest Expense
4834000
Quarters > 2 > income Statement > pretax Income
49942000
Quarters > 2 > income Statement > net Income
38441000
Quarters > 2 > income Statement > eps
0.2552275537455143
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
150614616
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
19.691589451741002
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
26091000
Quarters > 2 > balance Sheet > short Term Investments
4771000
Quarters > 2 > balance Sheet > receivables
173810000
Quarters > 2 > balance Sheet > inventories
154939000
Quarters > 2 > balance Sheet > total Current Assets
611897000
Quarters > 2 > balance Sheet > property Plant Equipment
733236000
Quarters > 2 > balance Sheet > total Assets
1485729000
Quarters > 2 > balance Sheet > payables
79561000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
646913000
Quarters > 2 > balance Sheet > equity
836655000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
38441000
Quarters > 2 > cash Flow > depreciation
19086000
Quarters > 2 > cash Flow > change In Working Capital
-6462000
Quarters > 2 > cash Flow > cash From Operations
48033000
Quarters > 2 > cash Flow > capital Expenditures
29883000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
8743000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
0.2552275537455143
Quarters > 2 > ratios > PB
0.7866873106836151
Quarters > 2 > ratios > ROE
4.594605900879096
Quarters > 2 > ratios > ROA
2.5873493752898407
Quarters > 2 > ratios > FCF
18150000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.0719307562439067
Quarters > 2 > health Score
58
Quarters > 3 > quarter
2024-10-31
Quarters > 3 > income Statement > revenue
229841000
Quarters > 3 > income Statement > cost Of Revenue
153274000
Quarters > 3 > income Statement > gross Profit
76567000
Quarters > 3 > income Statement > operating Expenses
194049000
Quarters > 3 > income Statement > operating Income
35792000
Quarters > 3 > income Statement > interest Expense
4802000
Quarters > 3 > income Statement > pretax Income
35910000
Quarters > 3 > income Statement > net Income
28894000
Quarters > 3 > income Statement > eps
0.1918406112724146
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
150614616
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
15.572504470481768
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
16778000
Quarters > 3 > balance Sheet > short Term Investments
6949000
Quarters > 3 > balance Sheet > receivables
151430000
Quarters > 3 > balance Sheet > inventories
152387000
Quarters > 3 > balance Sheet > total Current Assets
614175000
Quarters > 3 > balance Sheet > property Plant Equipment
725399000
Quarters > 3 > balance Sheet > total Assets
1479646000
Quarters > 3 > balance Sheet > payables
79182000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
648054000
Quarters > 3 > balance Sheet > equity
829603000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
28894000
Quarters > 3 > cash Flow > depreciation
18535000
Quarters > 3 > cash Flow > change In Working Capital
-21466000
Quarters > 3 > cash Flow > cash From Operations
24374000
Quarters > 3 > cash Flow > capital Expenditures
21127000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-5865000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
0.1918406112724146
Quarters > 3 > ratios > PB
0.7933745079513936
Quarters > 3 > ratios > ROE
3.4828707225022093
Quarters > 3 > ratios > ROA
1.9527643774254113
Quarters > 3 > ratios > FCF
3247000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.014127157469729073
Quarters > 3 > health Score
49
Annuals > 0 > quarter
2025-01-31
Annuals > 0 > income Statement > revenue
957091000
Annuals > 0 > income Statement > cost Of Revenue
634481000
Annuals > 0 > income Statement > gross Profit
322610000
Annuals > 0 > income Statement > operating Expenses
767135000
Annuals > 0 > income Statement > operating Income
189956000
Annuals > 0 > income Statement > interest Expense
13487000
Annuals > 0 > income Statement > pretax Income
183971000
Annuals > 0 > income Statement > net Income
149685000
Annuals > 0 > income Statement > eps
0.9938278500142377
Annuals > 0 > income Statement > dividends Per Share
22592000
Annuals > 0 > income Statement > shares Outstanding
150614616
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
19.84722455858429
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
23182000
Annuals > 0 > balance Sheet > short Term Investments
3249000
Annuals > 0 > balance Sheet > receivables
174888000
Annuals > 0 > balance Sheet > inventories
140445000
Annuals > 0 > balance Sheet > total Current Assets
588601000
Annuals > 0 > balance Sheet > property Plant Equipment
723490000
Annuals > 0 > balance Sheet > total Assets
1442269000
Annuals > 0 > balance Sheet > payables
95512000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
650000000
Annuals > 0 > balance Sheet > equity
790406000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
149685000
Annuals > 0 > cash Flow > depreciation
64978000
Annuals > 0 > cash Flow > change In Working Capital
12263000
Annuals > 0 > cash Flow > cash From Operations
224769000
Annuals > 0 > cash Flow > capital Expenditures
145296000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
1241000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
0.9938278500142377
Annuals > 0 > ratios > PB
0.8327187191392778
Annuals > 0 > ratios > ROE
18.937735796540007
Annuals > 0 > ratios > ROA
10.378438418907985
Annuals > 0 > ratios > FCF
79473000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.08303599135296434
Annuals > 0 > health Score
77
Annuals > 1 > quarter
2024-01-31
Annuals > 1 > income Statement > revenue
898602000
Annuals > 1 > income Statement > cost Of Revenue
582113000
Annuals > 1 > income Statement > gross Profit
316489000
Annuals > 1 > income Statement > operating Expenses
727679000
Annuals > 1 > income Statement > operating Income
170923000
Annuals > 1 > income Statement > interest Expense
7254000
Annuals > 1 > income Statement > pretax Income
185802000
Annuals > 1 > income Statement > net Income
151842000
Annuals > 1 > income Statement > eps
1.008149169267875
Annuals > 1 > income Statement > dividends Per Share
18878000
Annuals > 1 > income Statement > shares Outstanding
150614616
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
19.02099038283912
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
24357000
Annuals > 1 > balance Sheet > short Term Investments
1532000
Annuals > 1 > balance Sheet > receivables
165490000
Annuals > 1 > balance Sheet > inventories
138943000
Annuals > 1 > balance Sheet > total Current Assets
468338000
Annuals > 1 > balance Sheet > property Plant Equipment
637805000
Annuals > 1 > balance Sheet > total Assets
1231828000
Annuals > 1 > balance Sheet > payables
90644000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
539649000
Annuals > 1 > balance Sheet > equity
690431000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
151842000
Annuals > 1 > cash Flow > depreciation
51848000
Annuals > 1 > cash Flow > change In Working Capital
-13703000
Annuals > 1 > cash Flow > cash From Operations
181652000
Annuals > 1 > cash Flow > capital Expenditures
175524000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-1154000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
1.008149169267875
Annuals > 1 > ratios > PB
0.9532971027083083
Annuals > 1 > ratios > ROE
21.992349706198013
Annuals > 1 > ratios > ROA
12.32655857798329
Annuals > 1 > ratios > FCF
6128000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.0068194818173117795
Annuals > 1 > health Score
70
Annuals > 2 > quarter
2023-01-31
Annuals > 2 > income Statement > revenue
821144000
Annuals > 2 > income Statement > cost Of Revenue
524717000
Annuals > 2 > income Statement > gross Profit
296427000
Annuals > 2 > income Statement > operating Expenses
651807000
Annuals > 2 > income Statement > operating Income
169337000
Annuals > 2 > income Statement > interest Expense
2686000
Annuals > 2 > income Statement > pretax Income
158288000
Annuals > 2 > income Statement > net Income
125379000
Annuals > 2 > income Statement > eps
0.8324490898014838
Annuals > 2 > income Statement > dividends Per Share
11456000
Annuals > 2 > income Statement > shares Outstanding
150614616
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
20.62208333739271
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
28795000
Annuals > 2 > balance Sheet > short Term Investments
1489000
Annuals > 2 > balance Sheet > receivables
146428000
Annuals > 2 > balance Sheet > inventories
128936000
Annuals > 2 > balance Sheet > total Current Assets
554516000
Annuals > 2 > balance Sheet > property Plant Equipment
517209000
Annuals > 2 > balance Sheet > total Assets
1196500000
Annuals > 2 > balance Sheet > payables
99596000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
487456000
Annuals > 2 > balance Sheet > equity
707278000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
125379000
Annuals > 2 > cash Flow > depreciation
55357000
Annuals > 2 > cash Flow > change In Working Capital
1600000
Annuals > 2 > cash Flow > cash From Operations
182123000
Annuals > 2 > cash Flow > capital Expenditures
152688000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-2394000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
0.8324490898014838
Annuals > 2 > ratios > PB
0.9305900535857187
Annuals > 2 > ratios > ROE
17.726975814319122
Annuals > 2 > ratios > ROA
10.47881320518178
Annuals > 2 > ratios > FCF
29435000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.03584633145952476
Annuals > 2 > health Score
71
Annuals > 3 > quarter
2022-01-31
Annuals > 3 > income Statement > revenue
648668000
Annuals > 3 > income Statement > cost Of Revenue
422499000
Annuals > 3 > income Statement > gross Profit
226169000
Annuals > 3 > income Statement > operating Expenses
533419000
Annuals > 3 > income Statement > operating Income
115249000
Annuals > 3 > income Statement > interest Expense
1674000
Annuals > 3 > income Statement > pretax Income
123284000
Annuals > 3 > income Statement > net Income
100753000
Annuals > 3 > income Statement > eps
0.668945701790323
Annuals > 3 > income Statement > dividends Per Share
39824000
Annuals > 3 > income Statement > shares Outstanding
150614616
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
17.767024117113838
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
27859000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
117616000
Annuals > 3 > balance Sheet > inventories
83517000
Annuals > 3 > balance Sheet > total Current Assets
302157000
Annuals > 3 > balance Sheet > property Plant Equipment
334139000
Annuals > 3 > balance Sheet > total Assets
739895000
Annuals > 3 > balance Sheet > payables
63376000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
320477000
Annuals > 3 > balance Sheet > equity
417963000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
100753000
Annuals > 3 > cash Flow > depreciation
36444000
Annuals > 3 > cash Flow > change In Working Capital
744000
Annuals > 3 > cash Flow > cash From Operations
132213000
Annuals > 3 > cash Flow > capital Expenditures
98628000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
8816000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
0.668945701790323
Annuals > 3 > ratios > PB
1.5747467405488045
Annuals > 3 > ratios > ROE
24.105722276852255
Annuals > 3 > ratios > ROA
13.617202440886883
Annuals > 3 > ratios > FCF
33585000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.051775330369310646
Annuals > 3 > health Score
76
Valuation > metrics > PE
15.6071
Valuation > metrics > PB
0.7380560875459613
Valuation > final Score
100
Valuation > verdict
13.1% Undervalued
Profitability > metrics > ROE
3.762686662562529
Profitability > metrics > ROA
4.924413084219131
Profitability > metrics > Net Margin
0.13553030700815485
Profitability > final Score
43
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7904355656028429
Risk > metrics > Interest Coverage
7.575535616187511
Risk > final Score
78
Risk > verdict
Low
Liquidity > metrics > Current Ratio
6.55956449330471
Liquidity > metrics > Quick Ratio
4.875152822033328
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
58
Prev Profitabilities > 1
51
Prev Profitabilities > 2
40
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
78
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:34:06.235Z
Earnings History > 0 > period
2025-04-30
Earnings History > 0 > report Date
2025-06-30
Earnings History > 0 > date
2025-04-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.0858
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-01-31
Earnings History > 1 > report Date
2025-03-31
Earnings History > 1 > date
2025-01-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0672
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-10-31
Earnings History > 2 > report Date
2024-12-31
Earnings History > 2 > date
2024-10-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0512
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-07-31
Earnings History > 3 > report Date
2024-09-30
Earnings History > 3 > date
2024-07-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.0619
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-01-31
Earnings History > 4 > report Date
2024-03-31
Earnings History > 4 > date
2024-01-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0451
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-10-31
Earnings History > 5 > report Date
2023-12-31
Earnings History > 5 > date
2023-10-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.0793
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-07-31
Earnings History > 6 > report Date
2023-09-30
Earnings History > 6 > date
2023-07-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.0627
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-10-31
Earnings History > 7 > report Date
2022-12-31
Earnings History > 7 > date
2022-10-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.0646
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-07-31
Earnings History > 8 > report Date
2022-09-30
Earnings History > 8 > date
2022-07-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.0428
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
0.05261Next Payout:
Feb 23, 2026Yield:
4.8156 %(Last Updated 2025-07-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of SHTPY
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-04-30
EPS Actual
0.0858
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-07-31)
(Last Updated 2025-07-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-07-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-07-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.